About This Study
The purpose of this study is to find out which treatment works best to keep multiple myeloma from coming back after a stem cell transplant. Our researchers will compare three options: a new medicine called teclistamab with standard treatment called lenalidomide, lenalidomide alone, or teclistamab alone. The goal is to see which treatment helps people stay healthy longer.
What Activities Are a Part of this Study?
- Informed Consent Review
- Use of Study Treatments or Placebo
- Use of Study Health Plans
- After Study Follow-Up Activities
- Review of Medical History
- Physical Examinations
- Study Visits and Consultations
- Surveys/Questionnaires
- Laboratory and Imaging Tests
- Specimen Sample Collection
- Diary/e-Diary Writing or Recordings
Age & Gender
- 18 - 100+ years old
- Female
- Male
Language
- This study enrolls English and Spanish speakers
Additional Study Information
- No compensation provided
- Reimbursement offered
Study Locations
- Greater Charlotte, NC